- This event has passed.
Examining the Economic and Financial Case for Tackling NCDs
April 24, 2018 @ 8:00 am - 11:30 am EDT
Organized by RTI International
8:00 AM – 11:30 AM EDT
(The event will be live-streamed via webcast)
Please join RTI International and our international guests for a discussion of the economic and financial case for tackling noncommunicable diseases (NCDs). NCDs such as cancer, heart disease, and diabetes are major drivers of poverty worldwide. Investing in the treatment and prevention of NCDs not only produces major health gains–particularly for the poorest in society– but also provides economic benefits.
This event will spotlight The Lancet’s recently published NCD Economics Task Force Series, led by RTI’s Rachel Nugent. The five Task Force articles outline a common agenda for ministries of health, ministries of finance, and other ministries to use economic tools for NCD prevention and control efforts to achieve progress on nine Sustainable Development Goals (SDGs). The series addresses how:
1) Poverty stems from and exacerbates the burden of NCDs
2) Price policies can be effective pro-poor tools to prevent NCDs
3) Out-of-pocket medical spending on NCDs causes financial hardship
4) Cardiovascular disease prevention and control has a high benefit-cost ratio
The event will feature short presentations on the Task Force results by the Task Force experts, and recent NCD donor financing analysis by RTI. An international panel of distinguished NCD experts will participate in a roundtable discussion, followed by audience Q&A.
Breakfast will be provided starting at 8 AM, and the program will begin at 8:30 AM. Lunch will be provided following the event, starting at 11:30 AM.